Thema
Letter
SARS-CoV-2
1.610
COVID-19
1.243
Comment
555
Research Support, Non-U.S. Gov't
355
Spike Glycoprotein, Coronavirus
301
spike protein, SARS-CoV-2
292
Antibodies, Viral
288
COVID-19 Vaccines
270
Case Reports
141
Antibodies, Neutralizing
125
RNA, Viral
106
Angiotensin-Converting Enzyme 2
101
EC 3.4.17.23
101
Coronavirus
82
coronavirus
80
BNT162 Vaccine
75
ACE2 protein, human
71
N38TVC63NU
68
severe acute respiratory syndrome coronavirus 2
64
Antiviral Agents
61
Immunoglobulin G
61
Vaccination
61
viruses
61
Research Support, N.I.H., Extramural
59
Vaccines
58
respiratory infections
58
coronavirus disease
57
zoonoses
57
Omicron
56
SARS-CoV2
52
Pandemic
48
Covid-19
45
vaccine
42
EC 3.4.15.1
41
Peptidyl-Dipeptidase A
41
vaccination
38
ACE2
35
Antibodies, Monoclonal, Humanized
32
RT-PCR
31
Vaccine
31
RNA, Messenger
29
SARS-CoV-2 infection
29
Viral Vaccines
29
2019-nCoV Vaccine mRNA-1273
27
EPK39PL4R4
27
Public health
27
Biomarkers
26
Comparative Study
26
Coronavirus Nucleocapsid Proteins
26
mehr ...